Neonatal and adult cardiovascular pathophysiological remodeling and repair: Developmental role of periostin

Annals of the New York Academy of Sciences

Volumn 1123, Issue , 2008, Pages 30-40

  Norris, Russell A ^a   Borg, Thomas K ^b   Butcher, Jonathan T ^c   Baudino, Troy A ^b   Banerjee, Indroneal ^b   Markwald, Roger R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Cornell University   (United States)

Author keywords

Cardiac fibroblast; Fasciclin; Fibrosis; Heart failure; Hypertrophy; Myocardial infarction; Myocardial remodeling; Myocyte; Periostin

Indexed keywords

COLLAGEN; MATRICELLULAR PROTEIN; PROTEIN DERIVATIVE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADULT; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL REGENERATION; CONFERENCE PAPER; EMBRYO CELL; FIBROGENESIS; GENE DELETION; HEART DEVELOPMENT; HEART FAILURE; HEART VENTRICLE REMODELING; HEMATOPOIETIC STEM CELL; HYPOTHESIS; KNOCKOUT MOUSE; MESENCHYME CELL; MOUSE; MUSCLE CELL; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN SECRETION; STEM CELL; WILD TYPE;

MUS;

EID: 41149121601     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1420.005     Document Type: Conference Paper

References (52)

1. BORG, T.K., K. RUBIN, E. LUNDGREN, et al. 1984. Recognition of extracellular matrix components by neonatal and adult cardiac myocytes. Dev. Biol. 104: 86-96.
2. BORG, T.K., W.F. RANSON, F.A. MOSLEHY, et al. 1981. Structural basis of ventricular stiffness. Lab. Invest. 44: 49-54.
3. BANERJEE, I., K. YEKKALA, T.K. BORG, et al. 2006. Dynamic interactions between myocytes, fibroblasts, and extracellular matrix. Ann. N.Y. Acad. Sci. 1080: 76-84.
4. BAUDINO, T.A., W. CARVER, W. GILES, et al. 2006. Cardiac fibroblasts: friend or foe? Am. J. Physiol. Heart. Circ. Physiol. 291: H1015-1026.
5. WESSELS, A. & J.M. PEREZ-POMARES. 2004. The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 276: 43-57.
6. MANNER, J., J.M. PEREZ-POMARES, D. MACIAS, et al. 2001. The origin, formation and developmental significance of the epicardium: a review. Cells Tissues Organs 169: 89-103.
7. PEREZ-POMARES, J.M., A. PHELPS, M. SEDMEROVA, et al. 2002. Experimental studies on the spatiotemporal expression of WT1 and RALDH2 in the embryonic avian heart: a model for the regulation of myocardial and valvuloseptal development by epicardially derived cells (EPDCs). Dev Biol. 247: 307-326.
8. GITTENBERGER-DE GROOT, A.C., M.P. VRANCKEN PEETERS, M.M. MENTINK, et al. 1998. Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circ. Res. 82: 1043-1052.
9. SHIOJIMA, I., M. AIKAWA, J. SUZUKI, et al. 1999. Embryonic smooth muscle myosin heavy chain SMemb is expressed in pressure-overloaded cardiac fibroblasts. Jpn. Heart J. 40: 803-818.
10. WALKER, G.A., K.S. MASTERS, D.N. SHAH, et al. 2004. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ. Res. 95: 253-260.
11. VISCONTI, R.P. & R.R. MARKWALD. 2006. Recruitment of new cells into the postnatal heart: potential modification of phenotype by periostin. Ann. N.Y. Acad. Sci. 1080: 19-33.
12. EISENBERG, L.M. & R.R. MARKWALD. 2004. Cellular recruitment and the development of the myocardium. Dev. Biol. 274: 225-232.
13. EBIHARA, Y., M. MASUYA, A.C. LARUE, et al. 2006. Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Exp. Hematol. 34: 219-229.
14. VISCONTI, R.P., Y. EBIHARA, A.C. LAR UE, et al. 2006. An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells. Circ. Res. 98: 690-696.
15. GOODELL, M.A., K. BROSE, G. PARADIS, et al. 1996. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183: 1797-1806.
16. ORLIC, D., J. KAJSTURA, S. CHIMENTI, et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705.
17. MIRONOV, V., R.P. VISCONTI & R.R. MARKWALD. 2004. What is regenerative medicine? Emergence of applied stem cell and developmental biology. Expert Opin. Biol. Ther. 4: 773-781.
18. GOLDSMITH, E.C., A. HOFFMAN, M.O. MORALES, et al. 2004. Organization of fibroblasts in the heart. Dev. Dyn. 230: 787-794.
19. SNIDER, S., J. WANG, A. LINDSLEY, et al. 2007. Periostin is required for maturation and ECM stabilization of the cardiac skeleton. Circulation Research (Submitted).
20. KRUZYNSKA-FREJTAG, A., M. MACHNICKI, R. ROGERS, et al. 2001. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech. Dev. 103: 183-188.
21. LITVIN, J., S. ZHU, R. NORRIS, et al. 2005. Periostin family of proteins: therapeutic targets for heart disease. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 287: 1205-1212.
22. HORTSCH, M. & C.S. GOODMAN. 1990. Drosophila fasciclin I, a neural cell adhesion molecule, has a phosphatidylinositol lipid membrane anchor that is developmentally regulated. J. Biol. Chem. 265: 15104-15109.
23. TAKESHITA, S., R. KIKUNO, K. TEZUKA, et al. 1993. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem. J. 294(Pt 1): 271-278.
24. KIM, C.J., N. YOSHIOKA, Y. TAMBE, et al. 2005. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells. Int. J. Cancer 117: 51-58.
25. NORRIS, R.A., B. DAMON, V. MIRONOV, et al. 2007. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J. Cell Biochem.101: 659-711.
26. BAO, S., G. OUYANG, X. BAI, et al. 2004. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell. 5: 329-339.
27. GILLAN, L., D. MATEI, D.A. FISHMAN, et al. 2002. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 62: 5358-5364.
28. BUTCHER, J.T., R.A. NORRIS, S. HOFFMAN, et al. 2007. Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev. Biol. 302: 256-266.
29. BORNSTEIN, P. 2000. Matricellular proteins: an overview. Matrix Biol. 19: 555-556.
30. YANG, Z., T.R. KYRIAKIDES & P. BORNSTEIN. 2000. Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol. Biol. Cell. 11: 3353-3364.
31. MO, F.E. & L.F. LAU. 2006. The matricellular protein CCN1 is essential for cardiac development. Circ. Res. 99: 961-969.
32. KYRIAKIDES, T.R., Y.H. ZHU, Z. YANG, et al. 1998. The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice. J. Histochem. Cytochem. 46: 1007-1015.
33. OKA, T., J. XU, R.A. KAISER, et al. 2007. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circulation Research (Submitted).
34. BANERJEE, I., J.W. FUSELER, R.L. PRICE, et al. 2007. Determination of cell type and number during cardiac development in the neonatal and adult rat and mouse. Am. J. Physiol. Heart Circ. Physiol. 293: H1883-H1891.
35. COHN, J.N. 1995. Critical review of heart failure: the role of left ventricular remodeling in the therapeutic response. Clin. Cardiol. 18: IV4-12.
36. FEDAK, P.W., S. VERMA, R.D. WEISEL, et al. 2005. Cardiac remodeling and failure: from molecules to man (Part III). Cardiovasc. Pathol. 14: 109-119.
37. HEINEKE, J. & J.D. MOLKENTIN. 2006. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat.Rev. Mol. Cell. Biol. 7: 589-600.
38. OLSON, E.N. & M.D. SCHNEIDER. 2003. Sizing up the heart: development redux in disease. Genes Dev. 17: 1937-1956.
39. KATSURAGI, N., R. MORISHITA, N. NAKAMURA, et al. 2004. Periostin as a novel factor responsible for ventricular dilation. Circulation 110: 1806-1813.
40. STANTON, L.W., L.J. GARRARD, D. DAMM, et al. 2000. Altered patterns of gene expression in response to myocardial infarction. Circ. Res. 86: 939-945.
41. IEKUSHI, K., Y. TANIYAMA, J. AZUMA, et al. 2007. Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin. Hypertension. 49: 1409-1414.
42. FOO, R.S., K. MANI & R.N. KITSIS. 2005. Death begets failure in the heart. J. Clin. Invest. 115: 565-571.
43. KITSIS, R.N. & D.L. MANN. 2005. Apoptosis and the heart: a decade of progress. J. Mol. Cell. Cardiol. 38: 1-2.
44. DISPERSYN, G.D. & M. BORGERS. 2001. Apoptosis in the heart: about programmed cell death and survival. News Physiol. Sci. 16: 41-47.
45. DISPERSYN, G.D., L. MESOTTEN, B. MEURIS, et al. 2002. Dissociation of cardiomyocyte apoptosis and dedifferentiation in infarct border zones. Eur. Heart J. 23: 849-857.
46. LAFRAMBOISE, W.A., D. SCALISE, P. STOODLEY, et al. 2007. Cardiac fibroblasts influence cardiomyocyte phenotype in vitro. Am. J. Physiol. Cell. Physiol. 292: C1799-C1808.
47. KERN, C.B., S. HOFFMAN, R. MORENO, et al. 2005. Immunolocalization of chick periostin protein in the developing heart. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 284: 415-423.
48. KOLDITZ, D.P., M.C. WIJFFELS, N.A. BLOM, et al. 2007. Persistence of functional atrioventricular accessory pathways in postseptated embryonic avian hearts: implications for morphogenesis and functional maturation of the cardiac conduction system. Circulation 115: 17-26.
49. NORRIS, R.A., C.B. KERN, A. WESSELS, et al. 2004. Identification and detection of the periostin gene in cardiac development. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 281: 1227-1233.
50. GAUSSIN, V., G.E. MORLEY, L. COX, et al. 2005. Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus. Circ. Res. 97: 219-226.
51. OMENS, J.H. & Y.C. FUNG. 1990. Residual strain in rat left ventricle. Circ. Res. 66: 37-45.
52. OMENS, J.H., A.D. MCCULLOCH & J.C. CRISCIONE. 2003. Complex distributions of residual stress and strain in the mouse left ventricle: experimental and theoretical models. Biomech. Model Mechanobiol. 1: 267-277.